This Month in Psychopharmacology

THIS MONTH IN
PSYCHOPHARMACOLOGY

Browsing articles in "Anxiety/Stress-Related Disorders"

Paternal Prevalence of Comorbid Depression and Anxiety During First Two Years Postpartum
January 4, 2022

A recent longitudinally cohort study examined the prevalence of paternal comorbid depression and anxiety during the first and second year postpartum and investigated the predictors for comorbidity during the first and second-year following birth...

Generalized Anxiety Disorder Among Adults With Attention-Deficit Hyperactivity Disorder
December 13, 2021

Attention-deficit hyperactivity disorder and generalized anxiety disorder are highly comorbid; however, there are several potential confounding factors that must be accounted for to determine the degree of their association. Data from a nationally representative cross-sectional survey...

Continue reading (Members only)

Subthreshold PTSD Prevalent and Associated With Substantial Clinical Burden in Older U.S. Veterans
November 22, 2021

Subthreshold posttraumatic stress disorder (PTSD) is characterized by clinically significant PTSD symptoms below the threshold for diagnosis. It is not recognized as a diagnostic entity and is less well studied in older adults, despite its higher prevalence and potential clinical significance. In older adults, PTSD is associated with worse physical, cognitive, and social functioning, as well as...

Continue reading (Members only)

Psilocybin Therapy Increases Cognitive And Neural Flexibility In Patients With Major Depressive Disorder
November 18, 2021

Psilocybin therapy has shown promise in treating major depressive disorder and other psychiatric illnesses. However, the cognitive and neural mechanisms underlying its enduring efficacy is poorly understood. An open-label study examined the enduring effects of psilocybin therapy on the cognitive and neural flexibility...

2021 NEI Congress Child & Adolescent Psychiatry Academy
November 3, 2021

The 2021 NEI Congress is off to a strong start with the 5th Child and Adolescent Psychiatry Academy. Dr. Jeffrey Strawn opened the Academy with a topic of utmost importance as of late, pediatric anxiety. In this session...

Pediatricians, Psychiatrists, Children’s Hospitals Declare Emergency in Child Mental Health
October 21, 2021

The Academy of Pediatrics, The American Academy of Child and Adolescent Psychiatry, and the Children’s Hospital Association have declared a national emergency in the mental health of children and adolescents, stating the pandemic is a leading factor driving this crisis...

FDA Clears Stimulation Device for Decreasing Anxiety Symptoms in Depressed Patients
September 7, 2021

The U.S. Food and Drug Administration has approved marketing of a deep transcranial magnetic stimulation system for the treatment of comorbid anxiety symptoms in major depressive disorder, also known as anxious depression. As part of the indication...

Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease
August 27, 2021

Anxiety is common among patients with coronary heart disease (CHD); however, there is a dearth of studies examining efficacy of anxiety treatments in patients with CHD. A randomized clinical trial examined whether 12 weeks of aerobic exercise (3 times per week at an intensity of...

Patients With Social Anxiety Disorder Treated for Sleep Problems May Have Better Outcomes
June 15, 2021

Social anxiety disorder is associated with sleep disturbance, which may, in turn, interfere with learning and memory processes that are integral for exposure therapy. A recent study tested the relationships between exposure therapy outcomes and sleep disturbances both at baseline and before and after exposure-based therapy sessions in...

Addressing Mental Healthcare in the LGBTQ Community
June 11, 2021

NEI sat down with Drs. Rhonda Schwindt and Dr. Stephen Forssell for an expert discussion on disparities in the mental health care of lesbian, gay, bisexual, transgender and queer/questioning (LGBTQ) individuals...

Top of Page